| 0 |
HAEMOGLOBIN A2 |
1 |
0.5000 |
| 1 |
MANUAL LYMPHATIC DRAINAGE |
1 |
0.0769 |
| 2 |
ADMINISTRATION SITE MOVEMENT IMPAIRMENT |
1 |
0.0667 |
| 3 |
CHOROIDAL RUPTURE |
1 |
0.0526 |
| 4 |
VENOM POISONING |
1 |
0.0476 |
| 5 |
BLOOD FIBRINOGEN DECREASED |
32 |
0.0280 |
| 6 |
FASCIOTOMY |
3 |
0.0268 |
| 7 |
SNAKE BITE |
2 |
0.0200 |
| 8 |
BLOOD PRESSURE DIFFERENCE OF EXTREMITIES |
1 |
0.0172 |
| 9 |
PUNCTURE SITE PAIN |
4 |
0.0172 |
| 10 |
TONGUE NECROSIS |
1 |
0.0137 |
| 11 |
ELECTROCARDIOGRAM POOR R-WAVE PROGRESSION |
2 |
0.0136 |
| 12 |
PERIPHERAL PULSE DECREASED |
1 |
0.0103 |
| 13 |
PRODUCT RECONSTITUTION ISSUE |
3 |
0.0095 |
| 14 |
FINGER AMPUTATION |
7 |
0.0095 |
| 15 |
SKIN GRAFT FAILURE |
1 |
0.0094 |
| 16 |
PROTHROMBIN TIME RATIO INCREASED |
2 |
0.0092 |
| 17 |
ADMINISTRATION SITE EXTRAVASATION |
9 |
0.0090 |
| 18 |
HOUSE DUST ALLERGY |
1 |
0.0090 |
| 19 |
LABOUR INDUCTION |
1 |
0.0074 |
| 20 |
TISSUE INJURY |
3 |
0.0069 |
| 21 |
HAIR GROWTH RATE ABNORMAL |
1 |
0.0068 |
| 22 |
TRACHEAL OEDEMA |
1 |
0.0068 |
| 23 |
ADMINISTRATION SITE SWELLING |
2 |
0.0062 |
| 24 |
BLOOD LACTIC ACID DECREASED |
1 |
0.0058 |
| 25 |
COMPARTMENT SYNDROME |
15 |
0.0057 |
| 26 |
DEBRIDEMENT |
4 |
0.0052 |
| 27 |
EXSANGUINATION |
1 |
0.0050 |
| 28 |
PROTHROMBIN TIME PROLONGED |
30 |
0.0050 |
| 29 |
PULSE PRESSURE INCREASED |
1 |
0.0048 |
| 30 |
PHARYNGEAL INJURY |
1 |
0.0048 |
| 31 |
NEUROPSYCHIATRIC SYNDROME |
1 |
0.0045 |
| 32 |
NEUROMUSCULAR BLOCKADE |
1 |
0.0045 |
| 33 |
ACID BASE BALANCE ABNORMAL |
1 |
0.0045 |
| 34 |
SKIN GRAFT |
4 |
0.0043 |
| 35 |
PATIENT UNCOOPERATIVE |
2 |
0.0042 |
| 36 |
CALCIUM IONISED DECREASED |
1 |
0.0041 |
| 37 |
MYOGLOBIN URINE PRESENT |
1 |
0.0041 |
| 38 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME ABNORMAL |
1 |
0.0040 |
| 39 |
BLOOD FIBRINOGEN INCREASED |
3 |
0.0038 |
| 40 |
METAL POISONING |
2 |
0.0034 |
| 41 |
ENDOTRACHEAL INTUBATION COMPLICATION |
2 |
0.0034 |
| 42 |
TISSUE INFILTRATION |
1 |
0.0034 |
| 43 |
FIBRIN DEGRADATION PRODUCTS INCREASED |
1 |
0.0034 |
| 44 |
FIBRIN D DIMER INCREASED |
12 |
0.0034 |
| 45 |
PRODUCT RECONSTITUTION QUALITY ISSUE |
3 |
0.0034 |
| 46 |
MUSCLE NECROSIS |
3 |
0.0033 |
| 47 |
FASCIITIS |
2 |
0.0030 |
| 48 |
HYPOFIBRINOGENAEMIA |
3 |
0.0030 |
| 49 |
NEONATAL RESPIRATORY DEPRESSION |
1 |
0.0030 |
| 50 |
INFLAMMATION OF WOUND |
1 |
0.0030 |
| 51 |
COAGULOPATHY |
49 |
0.0029 |
| 52 |
PRODUCT COMPOUNDING QUALITY ISSUE |
1 |
0.0027 |
| 53 |
ECCHYMOSIS |
18 |
0.0026 |
| 54 |
ELECTROCARDIOGRAM QRS COMPLEX SHORTENED |
1 |
0.0026 |
| 55 |
COAGULATION TEST ABNORMAL |
2 |
0.0026 |
| 56 |
SERUM SICKNESS |
7 |
0.0025 |
| 57 |
NECROSIS |
13 |
0.0023 |
| 58 |
PRODUCT WITH QUALITY ISSUE ADMINISTERED |
1 |
0.0022 |
| 59 |
ANAPHYLACTOID REACTION |
9 |
0.0022 |
| 60 |
EPIDERMOLYSIS |
1 |
0.0022 |
| 61 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
11 |
0.0022 |
| 62 |
VEIN DISCOLOURATION |
1 |
0.0021 |
| 63 |
WOUND NECROSIS |
1 |
0.0021 |
| 64 |
VITREOUS DISORDER |
1 |
0.0021 |
| 65 |
HYPOCOAGULABLE STATE |
2 |
0.0021 |
| 66 |
THERAPY CHANGE |
17 |
0.0017 |
| 67 |
MUCOSAL HAEMORRHAGE |
2 |
0.0017 |
| 68 |
INFUSION RELATED HYPERSENSITIVITY REACTION |
1 |
0.0017 |
| 69 |
PUPILLARY DISORDER |
1 |
0.0016 |
| 70 |
EXTREMITY CONTRACTURE |
1 |
0.0016 |
| 71 |
DELIVERY |
1 |
0.0015 |
| 72 |
EXTRAVASATION |
6 |
0.0015 |
| 73 |
PCO2 INCREASED |
1 |
0.0014 |
| 74 |
PRODUCT SOLUBILITY ABNORMAL |
7 |
0.0014 |
| 75 |
RESPIRATORY TRACT OEDEMA |
1 |
0.0013 |
| 76 |
LOCAL REACTION |
1 |
0.0013 |
| 77 |
SKIN NECROSIS |
7 |
0.0013 |
| 78 |
SOFT TISSUE INJURY |
1 |
0.0013 |
| 79 |
TRACHEITIS |
1 |
0.0013 |
| 80 |
BLOOD BLISTER |
4 |
0.0013 |
| 81 |
LABORATORY TEST INTERFERENCE |
1 |
0.0013 |
| 82 |
TENDERNESS |
13 |
0.0012 |
| 83 |
INTERNATIONAL NORMALISED RATIO DECREASED |
5 |
0.0012 |
| 84 |
INCISION SITE HAEMORRHAGE |
1 |
0.0012 |
| 85 |
DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT |
1 |
0.0012 |
| 86 |
OCULAR VASCULAR DISORDER |
1 |
0.0012 |
| 87 |
SUPERFICIAL VEIN THROMBOSIS |
1 |
0.0012 |
| 88 |
LUNG HYPERINFLATION |
1 |
0.0012 |
| 89 |
ALCOHOL WITHDRAWAL SYNDROME |
1 |
0.0011 |
| 90 |
EXTREMITY NECROSIS |
2 |
0.0011 |
| 91 |
UPPER AIRWAY OBSTRUCTION |
1 |
0.0011 |
| 92 |
PNEUMOMEDIASTINUM |
2 |
0.0011 |
| 93 |
PRODUCT PREPARATION ISSUE |
7 |
0.0011 |
| 94 |
WOUND SECRETION |
4 |
0.0010 |
| 95 |
DIPLEGIA |
2 |
0.0010 |
| 96 |
SKIN OEDEMA |
1 |
0.0010 |
| 97 |
ANAPHYLACTIC REACTION |
53 |
0.0010 |
| 98 |
WALKING DISABILITY |
2 |
0.0010 |
| 99 |
SOFT TISSUE DISORDER |
1 |
0.0009 |
| 100 |
KOUNIS SYNDROME |
2 |
0.0009 |
| 101 |
HAEMATOCRIT INCREASED |
2 |
0.0009 |
| 102 |
ADMINISTRATION SITE PAIN |
1 |
0.0009 |
| 103 |
INTERCEPTED MEDICATION ERROR |
4 |
0.0009 |
| 104 |
DISSEMINATED INTRAVASCULAR COAGULATION |
12 |
0.0009 |
| 105 |
UNDERDOSE |
62 |
0.0008 |
| 106 |
STREPTOCOCCAL SEPSIS |
1 |
0.0008 |
| 107 |
PHARYNGEAL HAEMORRHAGE |
1 |
0.0008 |
| 108 |
BLOOD IMMUNOGLOBULIN G DECREASED |
2 |
0.0008 |
| 109 |
AMPUTATION |
1 |
0.0008 |
| 110 |
SWELLING |
75 |
0.0008 |
| 111 |
PRODUCT PREPARATION ERROR |
16 |
0.0008 |
| 112 |
IATROGENIC INJURY |
1 |
0.0008 |
| 113 |
DRUG EFFECT INCOMPLETE |
28 |
0.0008 |
| 114 |
HYPOXIC-ISCHAEMIC ENCEPHALOPATHY |
2 |
0.0008 |
| 115 |
IMMUNOGLOBULINS DECREASED |
1 |
0.0007 |
| 116 |
PULSELESS ELECTRICAL ACTIVITY |
3 |
0.0007 |
| 117 |
HAEMATOCRIT DECREASED |
14 |
0.0007 |
| 118 |
INTENSIVE CARE |
1 |
0.0007 |
| 119 |
INVESTIGATION ABNORMAL |
1 |
0.0007 |
| 120 |
GASTROINTESTINAL NECROSIS |
2 |
0.0007 |
| 121 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
2 |
0.0007 |
| 122 |
STRIDOR |
2 |
0.0007 |
| 123 |
COMPLEX REGIONAL PAIN SYNDROME |
1 |
0.0007 |
| 124 |
COAGULATION TIME PROLONGED |
1 |
0.0006 |
| 125 |
OPHTHALMOPLEGIA |
1 |
0.0006 |
| 126 |
INTERNATIONAL NORMALISED RATIO INCREASED |
18 |
0.0006 |
| 127 |
LOCAL SWELLING |
11 |
0.0006 |
| 128 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
17 |
0.0006 |
| 129 |
GAZE PALSY |
1 |
0.0006 |
| 130 |
BLOOD PH DECREASED |
1 |
0.0006 |
| 131 |
BLOOD CHLORIDE INCREASED |
1 |
0.0006 |
| 132 |
TREATMENT DELAYED |
1 |
0.0006 |
| 133 |
MUSCLE CONTRACTIONS INVOLUNTARY |
2 |
0.0006 |
| 134 |
INDURATION |
1 |
0.0006 |
| 135 |
THROMBOCYTOPENIA |
62 |
0.0006 |
| 136 |
WOUND HAEMORRHAGE |
2 |
0.0005 |
| 137 |
INJECTION SITE CELLULITIS |
1 |
0.0005 |
| 138 |
MECHANICAL VENTILATION |
1 |
0.0005 |
| 139 |
MENOMETRORRHAGIA |
1 |
0.0005 |
| 140 |
CONJUNCTIVAL HAEMORRHAGE |
2 |
0.0005 |
| 141 |
TRAUMATIC LUNG INJURY |
1 |
0.0005 |
| 142 |
PLATELET COUNT DECREASED |
54 |
0.0005 |
| 143 |
BRAIN INJURY |
5 |
0.0005 |
| 144 |
MUSCLE HAEMORRHAGE |
2 |
0.0005 |
| 145 |
PETECHIAE |
5 |
0.0005 |
| 146 |
LIVEDO RETICULARIS |
1 |
0.0005 |
| 147 |
TORTICOLLIS |
1 |
0.0005 |
| 148 |
INCORRECT DRUG ADMINISTRATION RATE |
2 |
0.0005 |
| 149 |
EXOPHTHALMOS |
1 |
0.0005 |
| 150 |
ELECTROCARDIOGRAM ST SEGMENT DEPRESSION |
1 |
0.0005 |
| 151 |
PRODUCT LOT NUMBER ISSUE |
1 |
0.0005 |
| 152 |
BLOOD PRESSURE DIASTOLIC INCREASED |
2 |
0.0004 |
| 153 |
HAEMANGIOMA |
1 |
0.0004 |
| 154 |
NEUROLOGICAL DECOMPENSATION |
1 |
0.0004 |
| 155 |
SKIN ABRASION |
2 |
0.0004 |
| 156 |
MOBILITY DECREASED |
30 |
0.0004 |
| 157 |
PERIPHERAL SWELLING |
64 |
0.0004 |
| 158 |
PULSE ABNORMAL |
1 |
0.0004 |
| 159 |
CATHETER SITE HAEMORRHAGE |
1 |
0.0004 |
| 160 |
PLATELET DISORDER |
1 |
0.0004 |
| 161 |
TOE AMPUTATION |
2 |
0.0004 |
| 162 |
SEDATION COMPLICATION |
1 |
0.0004 |
| 163 |
FOOD ALLERGY |
3 |
0.0004 |
| 164 |
ANAPHYLACTIC SHOCK |
10 |
0.0004 |
| 165 |
ANGIOEDEMA |
17 |
0.0004 |
| 166 |
AREFLEXIA |
1 |
0.0004 |
| 167 |
JOINT RANGE OF MOTION DECREASED |
5 |
0.0004 |
| 168 |
BLOOD SODIUM INCREASED |
1 |
0.0004 |
| 169 |
OEDEMA |
20 |
0.0004 |
| 170 |
SUBDURAL HAEMORRHAGE |
1 |
0.0004 |
| 171 |
TENOSYNOVITIS |
1 |
0.0004 |
| 172 |
VITREOUS HAEMORRHAGE |
1 |
0.0004 |
| 173 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
2 |
0.0004 |
| 174 |
MACULE |
1 |
0.0004 |
| 175 |
BLOOD UREA INCREASED |
6 |
0.0004 |
| 176 |
ENDOTRACHEAL INTUBATION |
1 |
0.0004 |
| 177 |
OXYGEN SATURATION ABNORMAL |
1 |
0.0004 |
| 178 |
PERONEAL NERVE PALSY |
2 |
0.0004 |
| 179 |
SKIN WARM |
2 |
0.0003 |
| 180 |
URINE OUTPUT DECREASED |
3 |
0.0003 |
| 181 |
BRADYCARDIA |
18 |
0.0003 |
| 182 |
RESPIRATORY RATE INCREASED |
3 |
0.0003 |
| 183 |
BRAIN HERNIATION |
1 |
0.0003 |
| 184 |
HYPOAESTHESIA ORAL |
5 |
0.0003 |
| 185 |
PLATELET COUNT ABNORMAL |
2 |
0.0003 |
| 186 |
THROMBOPHLEBITIS SUPERFICIAL |
1 |
0.0003 |
| 187 |
LARYNGEAL OEDEMA |
2 |
0.0003 |
| 188 |
BRAIN DEATH |
1 |
0.0003 |
| 189 |
BRAIN OEDEMA |
4 |
0.0003 |
| 190 |
ANTINUCLEAR ANTIBODY POSITIVE |
1 |
0.0003 |
| 191 |
PHARYNGEAL SWELLING |
3 |
0.0003 |
| 192 |
LYMPHOCYTE COUNT INCREASED |
1 |
0.0003 |
| 193 |
OEDEMA MOUTH |
1 |
0.0003 |
| 194 |
INFUSION SITE HAEMORRHAGE |
1 |
0.0003 |
| 195 |
EXPOSURE DURING BREAST FEEDING |
1 |
0.0003 |
| 196 |
GINGIVAL BLEEDING |
4 |
0.0003 |
| 197 |
BLOOD CREATININE ABNORMAL |
1 |
0.0003 |
| 198 |
HYPOPNOEA |
1 |
0.0003 |
| 199 |
POOR QUALITY PRODUCT ADMINISTERED |
3 |
0.0003 |
| 200 |
TYPE I HYPERSENSITIVITY |
1 |
0.0003 |
| 201 |
BONE EROSION |
1 |
0.0003 |
| 202 |
SINUS TACHYCARDIA |
4 |
0.0003 |
| 203 |
CONTUSION |
27 |
0.0003 |
| 204 |
BRONCHOSPASM |
4 |
0.0003 |
| 205 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
50 |
0.0003 |
| 206 |
PARAESTHESIA ORAL |
4 |
0.0003 |
| 207 |
VENTRICULAR ARRHYTHMIA |
1 |
0.0003 |
| 208 |
MOUTH HAEMORRHAGE |
2 |
0.0003 |
| 209 |
BLOOD PRESSURE DIASTOLIC DECREASED |
2 |
0.0003 |
| 210 |
PROTEIN TOTAL DECREASED |
1 |
0.0003 |
| 211 |
LOSS OF CONTROL OF LEGS |
1 |
0.0003 |
| 212 |
PRODUCT AVAILABILITY ISSUE |
6 |
0.0003 |
| 213 |
HAEMODYNAMIC INSTABILITY |
2 |
0.0003 |
| 214 |
TONGUE OEDEMA |
1 |
0.0003 |
| 215 |
ACIDOSIS |
2 |
0.0003 |
| 216 |
SKIN DISCOLOURATION |
12 |
0.0003 |
| 217 |
SHOCK |
6 |
0.0003 |
| 218 |
PRODUCT ADMINISTRATION INTERRUPTED |
2 |
0.0003 |
| 219 |
BLOOD DISORDER |
2 |
0.0002 |
| 220 |
ARTERIOSPASM CORONARY |
1 |
0.0002 |
| 221 |
SENSORY LOSS |
2 |
0.0002 |
| 222 |
MUSCLE TIGHTNESS |
4 |
0.0002 |
| 223 |
BODY TEMPERATURE INCREASED |
5 |
0.0002 |
| 224 |
URTICARIA |
41 |
0.0002 |
| 225 |
HYPERAESTHESIA |
2 |
0.0002 |
| 226 |
INJECTION SITE EXTRAVASATION |
3 |
0.0002 |
| 227 |
LEG AMPUTATION |
1 |
0.0002 |
| 228 |
ACCIDENTAL EXPOSURE |
1 |
0.0002 |
| 229 |
LABORATORY TEST ABNORMAL |
7 |
0.0002 |
| 230 |
LIP OEDEMA |
1 |
0.0002 |
| 231 |
ABSCESS LIMB |
1 |
0.0002 |
| 232 |
TENSION HEADACHE |
1 |
0.0002 |
| 233 |
ANURIA |
2 |
0.0002 |
| 234 |
HYPERSENSITIVITY |
43 |
0.0002 |
| 235 |
BLISTER |
13 |
0.0002 |
| 236 |
IMMOBILE |
1 |
0.0002 |
| 237 |
GROIN PAIN |
2 |
0.0002 |
| 238 |
ABDOMINAL ABSCESS |
1 |
0.0002 |
| 239 |
PHYSICAL DISABILITY |
1 |
0.0002 |
| 240 |
BLOOD PRESSURE SYSTOLIC DECREASED |
1 |
0.0002 |
| 241 |
HYPOTENSION |
44 |
0.0002 |
| 242 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
1 |
0.0002 |
| 243 |
EAR DISORDER |
1 |
0.0002 |
| 244 |
CELLULITIS |
11 |
0.0002 |
| 245 |
LOCALISED OEDEMA |
1 |
0.0002 |
| 246 |
DIARRHOEA HAEMORRHAGIC |
2 |
0.0002 |
| 247 |
SKIN TIGHTNESS |
1 |
0.0002 |
| 248 |
DIALYSIS |
3 |
0.0002 |
| 249 |
PULSE ABSENT |
1 |
0.0002 |
| 250 |
ACUTE RESPIRATORY FAILURE |
4 |
0.0002 |
| 251 |
GUILLAIN-BARRE SYNDROME |
1 |
0.0002 |
| 252 |
HYPERVOLAEMIA |
1 |
0.0002 |
| 253 |
HYPERAMMONAEMIA |
1 |
0.0002 |
| 254 |
SUBARACHNOID HAEMORRHAGE |
2 |
0.0002 |
| 255 |
PHLEBITIS |
1 |
0.0002 |
| 256 |
PERIPHERAL VASCULAR DISORDER |
1 |
0.0002 |
| 257 |
MUSCULOSKELETAL STIFFNESS |
17 |
0.0002 |
| 258 |
HAEMOGLOBIN DECREASED |
19 |
0.0002 |
| 259 |
WHITE BLOOD CELL COUNT INCREASED |
7 |
0.0002 |
| 260 |
NONSPECIFIC REACTION |
1 |
0.0002 |
| 261 |
INTESTINAL ISCHAEMIA |
1 |
0.0002 |
| 262 |
CHOKING SENSATION |
1 |
0.0002 |
| 263 |
BLOOD PRESSURE DECREASED |
12 |
0.0002 |
| 264 |
ERYTHEMA |
37 |
0.0002 |
| 265 |
NERVE INJURY |
2 |
0.0002 |
| 266 |
MULTI-ORGAN FAILURE |
3 |
0.0002 |
| 267 |
HEART RATE DECREASED |
6 |
0.0002 |
| 268 |
WHEEZING |
10 |
0.0002 |
| 269 |
CHOLECYSTITIS |
2 |
0.0002 |
| 270 |
GANGRENE |
1 |
0.0002 |
| 271 |
CYTOPENIA |
2 |
0.0002 |
| 272 |
INTERCEPTED PRODUCT PREPARATION ERROR |
2 |
0.0002 |
| 273 |
INFUSION SITE EXTRAVASATION |
1 |
0.0002 |
| 274 |
PRE-EXISTING CONDITION IMPROVED |
1 |
0.0002 |
| 275 |
DERMATITIS ALLERGIC |
2 |
0.0002 |
| 276 |
SCREAMING |
1 |
0.0002 |
| 277 |
WHITE BLOOD CELL COUNT ABNORMAL |
1 |
0.0002 |
| 278 |
OCCUPATIONAL EXPOSURE TO PRODUCT |
1 |
0.0002 |
| 279 |
HAEMOGLOBIN ABNORMAL |
1 |
0.0002 |
| 280 |
PLATELET COUNT INCREASED |
2 |
0.0002 |
| 281 |
IMMUNE SYSTEM DISORDER |
2 |
0.0002 |
| 282 |
ADVERSE REACTION |
2 |
0.0002 |
| 283 |
LIP SWELLING |
5 |
0.0001 |
| 284 |
SKIN MASS |
1 |
0.0001 |
| 285 |
PRODUCT ADMINISTRATION ERROR |
3 |
0.0001 |
| 286 |
POSTOPERATIVE WOUND INFECTION |
1 |
0.0001 |
| 287 |
LIMB INJURY |
4 |
0.0001 |
| 288 |
INFARCTION |
1 |
0.0001 |
| 289 |
RESPIRATION ABNORMAL |
1 |
0.0001 |
| 290 |
JOINT EFFUSION |
1 |
0.0001 |
| 291 |
RESPIRATORY DISTRESS |
4 |
0.0001 |
| 292 |
LYMPHOEDEMA |
1 |
0.0001 |
| 293 |
DEFAECATION URGENCY |
1 |
0.0001 |
| 294 |
INCORRECT DRUG ADMINISTRATION DURATION |
4 |
0.0001 |
| 295 |
THERMAL BURN |
1 |
0.0001 |
| 296 |
IMPAIRED WORK ABILITY |
3 |
0.0001 |
| 297 |
PARALYSIS |
2 |
0.0001 |
| 298 |
HYPOKINESIA |
2 |
0.0001 |
| 299 |
INFUSION RELATED REACTION |
9 |
0.0001 |
| 300 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0001 |
| 301 |
TACHYCARDIA |
12 |
0.0001 |
| 302 |
EYE SWELLING |
5 |
0.0001 |
| 303 |
BLOOD COUNT ABNORMAL |
2 |
0.0001 |
| 304 |
PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 305 |
PHARYNGEAL OEDEMA |
2 |
0.0001 |
| 306 |
PAIN |
79 |
0.0001 |
| 307 |
RASH |
56 |
0.0001 |
| 308 |
ELECTROCARDIOGRAM ABNORMAL |
1 |
0.0001 |
| 309 |
CYANOSIS |
2 |
0.0001 |
| 310 |
FURUNCLE |
1 |
0.0001 |
| 311 |
BLOOD ALBUMIN DECREASED |
1 |
0.0001 |
| 312 |
GINGIVAL PAIN |
1 |
0.0001 |
| 313 |
LOCALISED INFECTION |
3 |
0.0001 |
| 314 |
MUSCLE DISORDER |
1 |
0.0001 |
| 315 |
SHOCK HAEMORRHAGIC |
1 |
0.0001 |
| 316 |
ASPHYXIA |
1 |
0.0001 |
| 317 |
HEMIPLEGIA |
1 |
0.0001 |
| 318 |
PNEUMONIA ASPIRATION |
3 |
0.0001 |
| 319 |
RHABDOMYOLYSIS |
5 |
0.0001 |
| 320 |
INFUSION SITE ERYTHEMA |
1 |
0.0001 |
| 321 |
FACE OEDEMA |
2 |
0.0001 |
| 322 |
HEMIPARESIS |
2 |
0.0001 |
| 323 |
HAEMATURIA |
4 |
0.0001 |
| 324 |
UNRESPONSIVE TO STIMULI |
3 |
0.0001 |
| 325 |
BLOOD MAGNESIUM DECREASED |
1 |
0.0001 |
| 326 |
OEDEMA PERIPHERAL |
14 |
0.0001 |
| 327 |
NEUROTOXICITY |
2 |
0.0001 |
| 328 |
GRIP STRENGTH DECREASED |
1 |
0.0001 |
| 329 |
HYPOXIA |
4 |
0.0001 |
| 330 |
COLD SWEAT |
2 |
0.0001 |
| 331 |
ASPARTATE AMINOTRANSFERASE INCREASED |
6 |
0.0001 |
| 332 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
8 |
0.0001 |
| 333 |
MYOSITIS |
1 |
0.0001 |
| 334 |
HYPERHIDROSIS |
14 |
0.0001 |
| 335 |
FLANK PAIN |
1 |
0.0001 |
| 336 |
SUPRAVENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 337 |
POST PROCEDURAL COMPLICATION |
2 |
0.0001 |
| 338 |
BLOOD PRESSURE SYSTOLIC INCREASED |
2 |
0.0001 |
| 339 |
MENORRHAGIA |
2 |
0.0001 |
| 340 |
PRESCRIBED UNDERDOSE |
2 |
0.0001 |
| 341 |
DISCOMFORT |
6 |
0.0001 |
| 342 |
MOTOR DYSFUNCTION |
1 |
0.0001 |
| 343 |
ALANINE AMINOTRANSFERASE INCREASED |
6 |
0.0001 |
| 344 |
EXPOSURE DURING PREGNANCY |
6 |
0.0001 |
| 345 |
NERVOUS SYSTEM DISORDER |
3 |
0.0001 |
| 346 |
PRODUCT QUALITY ISSUE |
13 |
0.0001 |
| 347 |
HAEMORRHAGE |
10 |
0.0001 |
| 348 |
CLOSTRIDIUM DIFFICILE COLITIS |
1 |
0.0001 |
| 349 |
EPISTAXIS |
7 |
0.0001 |
| 350 |
MOVEMENT DISORDER |
3 |
0.0001 |
| 351 |
LIVER FUNCTION TEST INCREASED |
2 |
0.0001 |
| 352 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
2 |
0.0001 |
| 353 |
BLOOD CREATININE INCREASED |
6 |
0.0001 |
| 354 |
WOUND INFECTION |
1 |
0.0001 |
| 355 |
ASPIRATION |
1 |
0.0001 |
| 356 |
RENAL FAILURE |
12 |
0.0001 |
| 357 |
FOOT DEFORMITY |
1 |
0.0001 |
| 358 |
RASH MACULO-PAPULAR |
2 |
0.0001 |
| 359 |
GAIT INABILITY |
3 |
0.0001 |
| 360 |
INTESTINAL PERFORATION |
1 |
0.0001 |
| 361 |
OCULAR DISCOMFORT |
1 |
0.0001 |
| 362 |
BLOOD CALCIUM DECREASED |
1 |
0.0001 |
| 363 |
CHROMATURIA |
2 |
0.0001 |
| 364 |
EYELID OEDEMA |
1 |
0.0001 |
| 365 |
CEREBRAL HAEMORRHAGE |
3 |
0.0001 |
| 366 |
PRURITUS |
32 |
0.0001 |
| 367 |
NEURALGIA |
2 |
0.0001 |
| 368 |
NO THERAPEUTIC RESPONSE |
1 |
0.0001 |
| 369 |
CEREBRAL INFARCTION |
2 |
0.0001 |
| 370 |
RESPIRATORY DEPRESSION |
1 |
0.0001 |
| 371 |
LIVER INJURY |
2 |
0.0001 |
| 372 |
ABASIA |
2 |
0.0001 |
| 373 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
2 |
0.0001 |
| 374 |
HYPOAESTHESIA |
12 |
0.0001 |
| 375 |
OFF LABEL USE |
70 |
0.0001 |
| 376 |
MUSCLE ATROPHY |
1 |
0.0001 |
| 377 |
HAEMATEMESIS |
2 |
0.0001 |
| 378 |
PAIN IN EXTREMITY |
23 |
0.0001 |
| 379 |
MYDRIASIS |
1 |
0.0001 |
| 380 |
INFLAMMATION |
4 |
0.0001 |
| 381 |
HAEMATOMA |
2 |
0.0001 |
| 382 |
SWELLING FACE |
5 |
0.0001 |
| 383 |
JOINT STIFFNESS |
2 |
0.0001 |
| 384 |
PULMONARY CONGESTION |
1 |
0.0001 |
| 385 |
ABORTION SPONTANEOUS |
3 |
0.0001 |
| 386 |
HAEMATOCHEZIA |
4 |
0.0001 |
| 387 |
ORAL DISCOMFORT |
1 |
0.0001 |
| 388 |
NO ADVERSE EVENT |
13 |
0.0001 |
| 389 |
SKIN REACTION |
1 |
0.0001 |
| 390 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
2 |
0.0001 |
| 391 |
PARAESTHESIA |
11 |
0.0001 |
| 392 |
CARDIOGENIC SHOCK |
1 |
0.0001 |
| 393 |
RESPIRATORY FAILURE |
5 |
0.0001 |
| 394 |
AGITATION |
5 |
0.0001 |
| 395 |
DRUG EFFECT LESS THAN EXPECTED |
1 |
0.0001 |
| 396 |
SKIN HAEMORRHAGE |
1 |
0.0001 |
| 397 |
HAEMORRHAGE INTRACRANIAL |
1 |
0.0001 |
| 398 |
RESPIRATORY DISORDER |
2 |
0.0001 |
| 399 |
BLOOD POTASSIUM DECREASED |
2 |
0.0001 |
| 400 |
LACRIMATION INCREASED |
2 |
0.0001 |
| 401 |
CONDITION AGGRAVATED |
20 |
0.0001 |
| 402 |
DRUG ADMINISTRATION ERROR |
2 |
0.0001 |
| 403 |
SWOLLEN TONGUE |
2 |
0.0001 |
| 404 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
1 |
0.0001 |
| 405 |
PNEUMOTHORAX |
1 |
0.0001 |
| 406 |
METABOLIC ACIDOSIS |
2 |
0.0001 |
| 407 |
CHOLELITHIASIS |
2 |
0.0001 |
| 408 |
ACUTE KIDNEY INJURY |
9 |
0.0001 |
| 409 |
CIRCULATORY COLLAPSE |
1 |
0.0001 |
| 410 |
SCAR |
1 |
0.0001 |
| 411 |
AMENORRHOEA |
1 |
0.0001 |
| 412 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
1 |
0.0001 |
| 413 |
MATERNAL EXPOSURE DURING PREGNANCY |
5 |
0.0001 |
| 414 |
LEUKOCYTOSIS |
1 |
0.0001 |
| 415 |
PELVIC PAIN |
1 |
0.0001 |
| 416 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 417 |
PULMONARY EMBOLISM |
5 |
0.0001 |
| 418 |
MUSCULOSKELETAL DISORDER |
1 |
0.0001 |
| 419 |
DRUG PRESCRIBING ERROR |
1 |
0.0001 |
| 420 |
SKIN FISSURES |
1 |
0.0001 |
| 421 |
HEART RATE INCREASED |
5 |
0.0001 |
| 422 |
FLUSHING |
5 |
0.0000 |
| 423 |
CARDIAC ARREST |
4 |
0.0000 |
| 424 |
CARDIO-RESPIRATORY ARREST |
2 |
0.0000 |
| 425 |
DERMATITIS |
1 |
0.0000 |
| 426 |
GAIT DISTURBANCE |
9 |
0.0000 |
| 427 |
PRURITUS GENERALISED |
1 |
0.0000 |
| 428 |
DEEP VEIN THROMBOSIS |
3 |
0.0000 |
| 429 |
VAGINAL HAEMORRHAGE |
2 |
0.0000 |
| 430 |
PRODUCT DISPENSING ERROR |
1 |
0.0000 |
| 431 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
0.0000 |
| 432 |
TRANSAMINASES INCREASED |
1 |
0.0000 |
| 433 |
VOMITING |
21 |
0.0000 |
| 434 |
RASH PAPULAR |
1 |
0.0000 |
| 435 |
SNEEZING |
1 |
0.0000 |
| 436 |
THERAPEUTIC RESPONSE UNEXPECTED |
2 |
0.0000 |
| 437 |
THROAT IRRITATION |
2 |
0.0000 |
| 438 |
HEART RATE IRREGULAR |
1 |
0.0000 |
| 439 |
SKIN IRRITATION |
2 |
0.0000 |
| 440 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 441 |
CHEST PAIN |
8 |
0.0000 |
| 442 |
HYPERTENSION |
9 |
0.0000 |
| 443 |
OCULAR HYPERAEMIA |
2 |
0.0000 |
| 444 |
RASH ERYTHEMATOUS |
2 |
0.0000 |
| 445 |
MENTAL IMPAIRMENT |
1 |
0.0000 |
| 446 |
PRESYNCOPE |
1 |
0.0000 |
| 447 |
DYSPNOEA |
23 |
0.0000 |
| 448 |
CHEST DISCOMFORT |
4 |
0.0000 |
| 449 |
LOSS OF CONSCIOUSNESS |
5 |
0.0000 |
| 450 |
THERAPY CESSATION |
2 |
0.0000 |
| 451 |
PHARMACEUTICAL PRODUCT COMPLAINT |
1 |
0.0000 |
| 452 |
NERVOUSNESS |
2 |
0.0000 |
| 453 |
APPLICATION SITE ERYTHEMA |
1 |
0.0000 |
| 454 |
JAUNDICE |
1 |
0.0000 |
| 455 |
PALLOR |
1 |
0.0000 |
| 456 |
RESPIRATORY ARREST |
1 |
0.0000 |
| 457 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 458 |
FEELING COLD |
1 |
0.0000 |
| 459 |
OXYGEN SATURATION DECREASED |
2 |
0.0000 |
| 460 |
EYE PAIN |
2 |
0.0000 |
| 461 |
NAUSEA |
28 |
0.0000 |
| 462 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 463 |
DYSPHONIA |
2 |
0.0000 |
| 464 |
NASAL CONGESTION |
2 |
0.0000 |
| 465 |
URINARY INCONTINENCE |
1 |
0.0000 |
| 466 |
HEPATIC FAILURE |
1 |
0.0000 |
| 467 |
ADVERSE EVENT |
3 |
0.0000 |
| 468 |
DEATH |
27 |
0.0000 |
| 469 |
OSTEONECROSIS |
1 |
0.0000 |
| 470 |
ABDOMINAL PAIN |
7 |
0.0000 |
| 471 |
EXPIRED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 472 |
SYNCOPE |
3 |
0.0000 |
| 473 |
SKIN DISORDER |
1 |
0.0000 |
| 474 |
URINARY RETENTION |
1 |
0.0000 |
| 475 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
0.0000 |
| 476 |
FEELING ABNORMAL |
7 |
0.0000 |
| 477 |
MYOCARDIAL INFARCTION |
5 |
0.0000 |
| 478 |
C-REACTIVE PROTEIN INCREASED |
1 |
0.0000 |
| 479 |
PANIC ATTACK |
1 |
0.0000 |
| 480 |
DRUG INEFFECTIVE |
35 |
0.0000 |
| 481 |
BLOOD GLUCOSE INCREASED |
5 |
0.0000 |
| 482 |
UNEVALUABLE EVENT |
2 |
0.0000 |
| 483 |
INCORRECT DOSE ADMINISTERED |
6 |
0.0000 |
| 484 |
ANAEMIA |
5 |
0.0000 |
| 485 |
SEIZURE |
3 |
0.0000 |
| 486 |
PALPITATIONS |
3 |
0.0000 |
| 487 |
THROMBOSIS |
2 |
0.0000 |
| 488 |
SOMNOLENCE |
5 |
0.0000 |
| 489 |
EXTRA DOSE ADMINISTERED |
1 |
0.0000 |
| 490 |
FOETAL EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 491 |
ANXIETY |
7 |
0.0000 |
| 492 |
BLINDNESS |
1 |
0.0000 |
| 493 |
NEUTROPHIL COUNT DECREASED |
1 |
0.0000 |
| 494 |
VISUAL IMPAIRMENT |
3 |
0.0000 |
| 495 |
TREATMENT FAILURE |
2 |
0.0000 |
| 496 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 497 |
SKIN EXFOLIATION |
2 |
0.0000 |
| 498 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 499 |
RENAL FAILURE ACUTE |
1 |
0.0000 |
| 500 |
RECTAL HAEMORRHAGE |
1 |
0.0000 |
| 501 |
HYPOACUSIS |
1 |
0.0000 |
| 502 |
OVERDOSE |
5 |
0.0000 |
| 503 |
BALANCE DISORDER |
2 |
0.0000 |
| 504 |
SEPTIC SHOCK |
1 |
0.0000 |
| 505 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 506 |
ADVERSE DRUG REACTION |
2 |
0.0000 |
| 507 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 508 |
OROPHARYNGEAL PAIN |
2 |
0.0000 |
| 509 |
RENAL DISORDER |
1 |
0.0000 |
| 510 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 511 |
ARRHYTHMIA |
1 |
0.0000 |
| 512 |
DISEASE RECURRENCE |
1 |
0.0000 |
| 513 |
BLOOD GLUCOSE DECREASED |
1 |
0.0000 |
| 514 |
LUNG DISORDER |
1 |
0.0000 |
| 515 |
PYREXIA |
7 |
0.0000 |
| 516 |
DRY EYE |
1 |
0.0000 |
| 517 |
AGGRESSION |
1 |
0.0000 |
| 518 |
BLOOD PRESSURE INCREASED |
3 |
0.0000 |
| 519 |
ACCIDENTAL EXPOSURE TO PRODUCT |
2 |
0.0000 |
| 520 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
| 521 |
DEPRESSED MOOD |
1 |
0.0000 |
| 522 |
RASH PRURITIC |
1 |
0.0000 |
| 523 |
TREATMENT NONCOMPLIANCE |
1 |
0.0000 |
| 524 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 525 |
MEDICATION ERROR |
1 |
0.0000 |
| 526 |
MUSCULAR WEAKNESS |
2 |
0.0000 |
| 527 |
CHILLS |
2 |
0.0000 |
| 528 |
SURGERY |
1 |
0.0000 |
| 529 |
ARTHRALGIA |
7 |
0.0000 |
| 530 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 531 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 532 |
FEELING HOT |
1 |
0.0000 |
| 533 |
RHINORRHOEA |
1 |
0.0000 |
| 534 |
INJECTION SITE PRURITUS |
1 |
0.0000 |
| 535 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
3 |
0.0000 |
| 536 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 537 |
MULTIPLE SCLEROSIS RELAPSE |
1 |
0.0000 |
| 538 |
VISION BLURRED |
2 |
0.0000 |
| 539 |
BURNING SENSATION |
1 |
0.0000 |
| 540 |
INJURY |
1 |
0.0000 |
| 541 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 542 |
INFECTION |
2 |
0.0000 |
| 543 |
DYSGEUSIA |
1 |
0.0000 |
| 544 |
HEADACHE |
8 |
0.0000 |
| 545 |
CARDIAC FAILURE |
1 |
0.0000 |
| 546 |
DRUG DOSE OMISSION |
2 |
0.0000 |
| 547 |
COMPLETED SUICIDE |
1 |
0.0000 |
| 548 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 549 |
CEREBROVASCULAR ACCIDENT |
2 |
0.0000 |
| 550 |
MYALGIA |
2 |
0.0000 |
| 551 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 552 |
WEIGHT DECREASED |
3 |
0.0000 |
| 553 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 554 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 555 |
DIARRHOEA |
6 |
0.0000 |
| 556 |
PNEUMONIA |
3 |
0.0000 |
| 557 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 558 |
CONSTIPATION |
2 |
0.0000 |
| 559 |
SEPSIS |
1 |
0.0000 |
| 560 |
WEIGHT INCREASED |
2 |
0.0000 |
| 561 |
ASTHMA |
1 |
0.0000 |
| 562 |
DEPRESSION |
2 |
0.0000 |
| 563 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 564 |
BACK PAIN |
2 |
0.0000 |
| 565 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 566 |
JOINT SWELLING |
1 |
0.0000 |
| 567 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 568 |
FATIGUE |
6 |
0.0000 |
| 569 |
INSOMNIA |
2 |
0.0000 |
| 570 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 571 |
COUGH |
2 |
0.0000 |
| 572 |
HOSPITALISATION |
1 |
0.0000 |
| 573 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 574 |
TREMOR |
1 |
0.0000 |
| 575 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 576 |
MUSCLE SPASMS |
1 |
0.0000 |
| 577 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 578 |
MALAISE |
2 |
0.0000 |
| 579 |
DECREASED APPETITE |
1 |
0.0000 |
| 580 |
DIZZINESS |
2 |
0.0000 |
| 581 |
ASTHENIA |
1 |
0.0000 |